Your browser doesn't support javascript.
loading
Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity.
Flickinger, John C; Singh, Jagmohan; Carlson, Robert; Leong, Elinor; Baybutt, Trevor R; Barton, Joshua; Caparosa, Ellen; Pattison, Amanda; Rappaport, Jeffrey A; Roh, Jamin; Zhan, Tingting; Bashir, Babar; Waldman, Scott A; Snook, Adam E.
Afiliação
  • Flickinger JC; Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Singh J; Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Carlson R; Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Leong E; Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Baybutt TR; Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Barton J; Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Caparosa E; Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Pattison A; Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, United States.
  • Rappaport JA; Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Roh J; Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Zhan T; Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Bashir B; Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Waldman SA; Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Snook AE; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States.
J Immunother Cancer ; 8(2)2020 08.
Article em En | MEDLINE | ID: mdl-32819976
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Enterotoxina / Imunoterapia Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Enterotoxina / Imunoterapia Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article